Skip to main content

Table 1 Patients’ backgrounds

From: Long-term dynamics of hematological data and spleen volume in cirrhotic patients after liver transplantation-various dynamics depending on etiology

 

All

HBV

HCV

PBC

NBNC

n

53

19

6

13

15

Recipient Age (years old)

19-61(52)

40-61(53)

55-61(57)

27-58(52)

19-55(32)

Recipient Sex (M/F)

30/23

16/3

5/1

0/13

9/6

Donor Age (years old)

20-60(33)

20-60(34)

24-54(26.5)

21-60(33)

25-54(32)

Donor Sex (M/F)

30/23

8/11

5/1

7/6

10/5

Creatinine (mg/dl)

0.25-13.90(0.70)

0.50-13.90(0.80)

0.60-1.20(0.80)

0.40-1.00(0.63)

0.25-1.48(0.64)

Total Bilirubin (mg/dl)

0.3-41.0(4.4)

0.5-8.4(2.3)

1.0-18.5(1.9)

2.1-41.0(13.2)

0.3-37.3(10.2)

PT-INR

1.01-3.34(1.49)

1.15-3.04(1.63)

1.29-2.63(1.47)

1.24-2.18(1.54)

1.01-3.34(1.39)

MELD score

8.4-29.2(17.7)

9.0-27.4(16.6)

10.7-12.7(12.9)

11.5-29.2(19.6)

8.4-26.7(18.2)

Follow up period

13-104(60)

15-104(47)

45-78(71.5)

13-98(51)

16-97(60)

  1. HBV Hepatitis B virus, HCV Hepatitis C virus, PBC Primary Biliary Cirrhosis, NBNC nonB, nonC, M Male, F Female, PT-INR Prothrombin Time-International Normalized Ratio.
  2. Data are shown as minimum-maximum range, with median in parenthesis.